LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,328.00
-82.00 (-5.82%)
May 15, 2026, 3:30 PM KST
Market Cap104.68B -35.2%
Revenue (ttm)88.16B +2.6%
Net Income-64.37B
EPS-867.00
Shares Out74.24M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,608,072
Average Volume10,467,989
Open1,406.00
Previous Close1,410.00
Day's Range1,327.00 - 1,423.00
52-Week Range1,209.00 - 3,285.00
Betan/a
RSI47.07
Earnings DateApr 3, 2026

About LabGenomics

LabGenomics Co., Ltd. engages in the provision of various genetic molecular diagnostic products and services. It offers Next Generation Sequencing (NGS) and Molecular Diagnostics. The company was founded on March 29, 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2002
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 084650
Full Company Profile

Financial Performance

In 2025, LabGenomics's revenue was 88.16 billion, an increase of 2.63% compared to the previous year's 85.90 billion. Losses were -64.37 billion, 170.5% more than in 2024.

Financial Statements